Q: ALT: US What is your impression on this clinical stage bio pharmaceutical company ?
Do these small bio pharma companies have any chance of being a take out target from the larger player?
What is your risk assessment on this company
From 1-10 . 1 being high risk . 10 being low risk.
Thanks
Cal .
Do these small bio pharma companies have any chance of being a take out target from the larger player?
What is your risk assessment on this company
From 1-10 . 1 being high risk . 10 being low risk.
Thanks
Cal .